Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Depreciation & Amortization (2016 - 2017)

Historic Accumulated Depreciation & Amortization for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to $573025.0.

  • Tenax Therapeutics' Accumulated Depreciation & Amortization fell 519.03% to $573025.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $573025.0, marking a year-over-year decrease of 519.03%. This contributed to the annual value of $567625.0 for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Accumulated Depreciation & Amortization is $573025.0, which was down 519.03% from $575081.0 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $999003.0 in Q1 2013 and a low of $567625.0 during Q4 2016
  • In the last 4 years, Tenax Therapeutics' Accumulated Depreciation & Amortization had a median value of $604395.0 in 2016 and averaged $691828.6.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first tumbled by 2417.55% in 2016, then crashed by 519.03% in 2017.
  • Over the past 4 years, Tenax Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $828752.0 in 2013, then decreased by 9.67% to $748604.0 in 2015, then fell by 24.18% to $567625.0 in 2016, then rose by 0.95% to $573025.0 in 2017.
  • Its last three reported values are $573025.0 in Q3 2017, $575081.0 for Q2 2017, and $571657.0 during Q1 2017.